ATE510819T1 - Neue rar rezeptor aktivierende liganden und deren verwendung in der humanmedizin und der kosmetik - Google Patents

Neue rar rezeptor aktivierende liganden und deren verwendung in der humanmedizin und der kosmetik

Info

Publication number
ATE510819T1
ATE510819T1 AT04791557T AT04791557T ATE510819T1 AT E510819 T1 ATE510819 T1 AT E510819T1 AT 04791557 T AT04791557 T AT 04791557T AT 04791557 T AT04791557 T AT 04791557T AT E510819 T1 ATE510819 T1 AT E510819T1
Authority
AT
Austria
Prior art keywords
cosmetics
human medicine
rar receptor
new rar
ligands
Prior art date
Application number
AT04791557T
Other languages
English (en)
Inventor
Thibaud Biadatti
Anne-Pascale Luzy
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Application granted granted Critical
Publication of ATE510819T1 publication Critical patent/ATE510819T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
AT04791557T 2003-10-17 2004-10-15 Neue rar rezeptor aktivierende liganden und deren verwendung in der humanmedizin und der kosmetik ATE510819T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0312154A FR2861069B1 (fr) 2003-10-17 2003-10-17 NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE
PCT/FR2004/002646 WO2005037772A2 (fr) 2003-10-17 2004-10-15 NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE

Publications (1)

Publication Number Publication Date
ATE510819T1 true ATE510819T1 (de) 2011-06-15

Family

ID=34385243

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04791557T ATE510819T1 (de) 2003-10-17 2004-10-15 Neue rar rezeptor aktivierende liganden und deren verwendung in der humanmedizin und der kosmetik

Country Status (8)

Country Link
US (1) US7439396B2 (de)
EP (1) EP1680395B1 (de)
AR (1) AR046111A1 (de)
AT (1) ATE510819T1 (de)
CA (1) CA2539059C (de)
ES (1) ES2366627T3 (de)
FR (1) FR2861069B1 (de)
WO (1) WO2005037772A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2931661B1 (fr) 2008-05-30 2010-07-30 Galderma Res & Dev Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide.
MX2012012092A (es) 2010-04-19 2012-12-17 Metabolic Solutions Dev Co Llc Sintesis novedosa para compuestos de tiazolidinadiona.
PL2603498T3 (pl) 2010-08-10 2017-06-30 Octeta Therapeutics, Llc Nowa synteza związków tiazolidynodionu
US8895748B2 (en) 2010-08-10 2014-11-25 Metabolic Solutions Development Company, Llc Synthesis for thiazolidinedione compounds
FR2991172A1 (fr) 2012-06-01 2013-12-06 Galderma Res & Dev Compositions pharmaceutiques topiques comprenant des microcapsules
FR2991171B1 (fr) 2012-06-01 2014-05-23 Galderma Res & Dev Procede de preparation d'une composition dermatologique comprenant des oleosomes
WO2013178749A1 (fr) 2012-06-01 2013-12-05 Galderma Research & Development Nanocapsules lipidiques comprenant un rétinoide, nanodispersion et composition les contenant, leur procédé de préparation et leur utilisation en dermatologie
FR2991174B1 (fr) 2012-06-01 2014-12-26 Galderma Res & Dev Composition dermatologique comprenant des oleosomes et des retinoides, son procede de preparation et son utilisation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124455A (en) * 1990-08-08 1992-06-23 American Home Products Corporation Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
WO1994015901A1 (en) * 1993-01-11 1994-07-21 Ligand Pharmaceuticals Inc. Compounds having selectivity for retinoid x receptors
FR2750426B1 (fr) * 1996-06-28 1998-08-07 Cird Galderma Nouveaux composes biaryles heterocycliques et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetique
EP1066821A1 (de) * 1999-07-08 2001-01-10 Haarmann & Reimer Gmbh Topische kosmetische Mittel, enthaltend Benzaldoxime
DE19960105A1 (de) * 1999-12-14 2001-06-21 Haarmann & Reimer Gmbh Catecholoxime und ihre Verwendung in kosmetischen und dermatologischen Zubereitungen

Also Published As

Publication number Publication date
ES2366627T3 (es) 2011-10-24
US7439396B2 (en) 2008-10-21
WO2005037772A2 (fr) 2005-04-28
EP1680395B1 (de) 2011-05-25
CA2539059C (fr) 2013-02-12
EP1680395A2 (de) 2006-07-19
FR2861069B1 (fr) 2005-12-09
US20070004726A1 (en) 2007-01-04
CA2539059A1 (fr) 2005-04-28
WO2005037772A3 (fr) 2005-09-01
FR2861069A1 (fr) 2005-04-22
AR046111A1 (es) 2005-11-23

Similar Documents

Publication Publication Date Title
CY2022031I1 (el) Νεοι συνδετες που διαμορφωνουν τους υποδοχεις rαr, και χρηση αυτων στην ιατρικη για τον ανθρωπο και στα καλλυντικα
FR20C1025I2 (fr) Nouveaux ligands qui modulent les recepteurs rar, et leur utilisation en medecine et en cosmetique
ATE381335T1 (de) 2-cyanopyrrolopyrimidine und deren pharmazeutische verwendung
PL379553A1 (pl) Ligandy receptora waniloidowego oraz ich zastosowanie w leczeniu
ATE420084T1 (de) Neue imidazolderivate und deren verwendung als pharmazeutische mittel
IL166396A0 (en) Vanilloid receptor ligands and their use in treatments
BRPI0307237A2 (pt) uso de pigmentos de camadas múltiplas no setor de alimentos e de produtos farmacêuticos
ATE425979T1 (de) Neue substituierte imidazo-pyridinone und imidazo-pyridazinone, ihre herstellung und ihre verwendung als arzneimittel
EP1832272A4 (de) Modifiziertes pulver und dieses verwendende kosmetische zusammensetzung
ATE529420T1 (de) 3-ä(2-ää4-hexyloxycarbonylamino-imino-methyl)- phenylaminoü-methylü-1-methyl-1h-benzimidazol-5 carbonyl)-pyridin-2-yl-aminoü-propionsäure- ethylester-methansulfonat-hemihydrat und dessen verwendung als arzneimittel
IL173013A0 (en) New branched sulfates for use in personal care formulations
ATE469631T1 (de) Verbesserungen in pulverpressung und beschichtung
IL173398A0 (en) Pyridyl derivatives and their use as therapeutic agents
TWI349551B (en) Thiophenepyrimidinone derivatives and their use in therapy
EP1572724A4 (de) Kdr und vegf/kdr bindungspeptide und ihre verwendung bei der diagnose und therapie
AU2003278807A8 (en) KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
DE602004024338D1 (de) Pflanzenextrakt und seine pharmazeutische und kosmetische verwendung
ATE447570T1 (de) Pyrimidinderivate zur verwendung als vanilloidrezeptorliganden und deren verwendung bei der behandlung von schmerzen
IL179245A0 (en) Piperazin derivatives and their use in controlling pests
DE69919414D1 (de) Inverser latex und verwendung in der kosmetik
ATE510819T1 (de) Neue rar rezeptor aktivierende liganden und deren verwendung in der humanmedizin und der kosmetik
IL182385A0 (en) Pyridine derivatives and the preparation and the therapeutic use thereof
DE602004022169D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
ATE432254T1 (de) Neue liganden, bei denen es sich um aktivatoren des rar-rezeptors handelt, verwendung in der humanmedizin und in kosmetika
DK1660532T3 (da) Fusionspolypeptider, og anvendelse deraf i antivaskulær tumorterapi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties